Drug intelligence / Profile preview

Femitone

Development stage: Unknown
Lead developer: Ritz Pharma
Administration: Oral

Overview

Femitone is an Ayurvedic uterine tonic developed and marketed by Ritz Pharma. Formulated as an oral syrup, it is a polyherbal preparation intended to support female reproductive health and manage various gynecological conditions. As a botanical product rooted in traditional Ayurvedic medicine, it typically utilizes a blend of plant extracts known for their astringent and tonifying effects on the uterine musculature and their ability to help regulate menstrual cycles. The product is currently marketed and approved for use as a general uterine tonic.

Brand names: Femitone
Other names: Femitone SyrupFemitone Syp.

Beyond the preview

Go deeper on Femitone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Femitone.

Explore the full profile